Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease

Table 4

Behcet’s disease, average visual acuity efficiency coefficient dependent on treatment and presence of macular edema.

	𝑁	Initial examination1	Follow-up examination2	Sig.1,2
Treatment
Dexasone subconjunctival	10	0.4 ± 0.37	0.5 ± 0.39	0.404
Systemic corticosteroids (prednisolone)	7	0.6 ± 0.39	0.7 ± 0.33	𝟎.𝟎𝟔𝟖^¥
Cyclosporine A and prednisolone	27	0.6 ± 0.37	0.6 ± 0.39	0.667
Corticosteroid (dexasone) drops	23	0.6 ± 0.38	0.6 ± 0.39	0.990
Cytostatic drugs	6	0.5 ± 0.40	0.6 ± 0.42	𝟎.𝟎𝟓𝟏^¥
Laser PHC	23	0.8 ± 0.33	0.8 ± 0.29	0.825
Macular edema
Laser PHC and triamcinolone acetonide (sub-Tenon’s injections)	11	0.6 ± 0.38	0.7 ± 0.38	𝟎.𝟎𝟑𝟖^∗

∗Significance 𝑃<0.05.
^¥Significance 𝑃<0.10.